Bandera Partners AUM, Performance, Holdings
While following many hedge funds can be a good idea to identify profitable investment opportunities, following activist investors can be even more rewarding and often in a shorter...
Posts Tagged ‘NASDAQ:PPHM’
13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)
You can access the original SEC filing by clicking here.
13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)
You can access the original SEC filing by clicking here.
Top 10 Penny Stocks To Buy in 2017
What are the top 10 penny stocks to buy in 2017? Out of thousands of stocks that are trading at price levels below $1.00, it can be hard to identify winning picks, especially ...
13D Filing: Ronin Capital, LLC and Peregrine Pharmaceuticals Inc (PPHM)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...
Is Peregrine Pharmaceuticals (PPHM) A Good Stock To Buy?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
5 Biotech Penny Stocks Smart Money Is Piling On
Apart from technology, if there ever was a sector that short sellers were afraid to touch for fear of being squeezed out vehemently, it has to be biotech.
Why These Five Stocks Are in Spotlight on Friday
The US stock market (similar to the markets around the world) is slightly in green today before the G-20 summit that will take place this weekend.
Should You Buy Peregrine Pharmaceuticals (PPHM)?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits
Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...
Peregrine Pharmaceuticals (PPHM), Sanofi SA (ADR) (SNY): Is This Experimental Lung Cancer Drug Back on Track?
Peregrine Pharmaceuticals (NASDAQ:PPHM), a developmental stage biotech focusing on oncology treatments, recently announced that its lead drug candidate, bavituximab, was heading...
Intuitive Surgical, Inc. (ISRG), CSX Corporation (CSX): Three Predictions for Next Week
I predicted that Noodles & Co (NASDAQ:NDLS) would close lower on the week.
IMAX Corporation (USA) (IMAX), Constellation Brands, Inc. (STZ): Three Predictions for Next Week
I predicted that IMAX Corporation (USA) (NYSE:IMAX) would close higher on the week.
AcelRx Pharmaceuticals Inc (ACRX), Peregrine Pharmaceuticals (PPHM): This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
MannKind Corporation (MNKD) News: Substantial Take Off, Zacks Score and More
An enormous call trade tops today's option activity in biopharmaceutical company MannKind Corporation (NASDAQ:MNKD) as takeover speculation rises.
Alcoa Inc (AA), American Express Company (AXP): These Winners Couldn’t Send the Dow Jones Industrial Average (.DJI) to Another Record
If you look through some explanations of why the Dow Jones Industrial Average (Dow Jones Indices:.DJI) failed to set a new record today, you'll find a common theme: Investors...
3 Stocks That Blew the Market Away: Costco Wholesale Corporation (COST), Renren Inc (RENN), Peregrine Pharmaceuticals (PPHM)
I take a look at three companies that beat market expectations every week, since I believe that it's the biggest factor in a stock beating the market.
5 Reasons Not to Worry This Week: Diamond Foods, Inc. (DMND), Ebix Inc (EBIX), TICC Capital Corp. (TICC)
The snack giant is trying to get beyond an embarrassing couple of years.
Peregrine Pharmaceuticals (PPHM) Earnings: An Early Look – Celgene Corporation (CELG)
Earnings season is winding down, with most companies already having reported their quarterly results.
2 of These 3 Stocks Look Like Damaged Goods: Cliffs Natural Resources Inc (CLF) and More
It's not even a case of two steps forward, one step back.
Peregrine Pharmaceuticals (PPHM)’s Epic Failure (Maybe)
Clinical trial 101 says if a trial passes all of its primary endpoints it's successful. If it doesn't, it's not.
What’s Moving These Biotech Stocks? – Novo Nordisk (NVO), Peregrine Pharmaceuticals (PPHM)
Typically, it doesn't take a lot for a stock to trade with gains/losses of more than 5% in a session; it can be caused by an analyst's remarks, sometimes it's caused by earnings...
Peregrine Pharmaceuticals (PPHM): 50% Upside on this Biotechnology Stock
The patent cliff has positively impacted the valuations of small biopharmaceutical companies due to their acquisition potential.
3 Biotechs Burning Through Cash: Keryx Biopharmaceuticals (KERX), Peregrine Pharmaceuticals (PPHM) and More
Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry does. They go years without generating any revenue.
